Fahr syndrome associated with post-thyroidectomy hypoparathyroidism
Author(s) -
Isabela Silva Souza,
Beatriz Cassarotti,
Lucas de Oliveira Pinto Bertoldi,
Alana Strucker Barbosa,
Eduardo Silveira Marques Branco,
Isabela Badan Fernandes,
Bruno Eji Nakano,
Gabriel Flamarin Cavasana,
Paula Carolina Grande Nakazato,
Carla Ferreira Santos,
Stella Kawano de Oliveira,
Luiz Domingos Mendes Melges,
Fábio de Araujo Pereira,
Natalia Samadello Melges,
Luiz Henrique Stefano
Publication year - 2021
Publication title -
sao paulo medical journal
Language(s) - English
Resource type - Conference proceedings
eISSN - 1806-9460
pISSN - 1516-3180
DOI - 10.5327/1516-3180.567
Subject(s) - hypoparathyroidism , medicine , hyperphosphatemia , basal ganglia disease , basal ganglia , context (archaeology) , thyroidectomy , surgery , endocrinology , thyroid , calcium , central nervous system , paleontology , biology
Context: Fahr’s syndrome is a rare disorder characterized by bilateral and symmetrical abnormal calcifications in basal ganglia and cerebral cortex. Those calcified deposits are due to changes in calcium and phosphorus metabolisms that can be caused by endocrine disorders, mitochondrial myopathies, dermatological and infectious diseases. Clinical manifestations may include a variety of extrapyramidal, cerebelar and neuropsychiatric syndromes. Case report: This study describes a 75-year-old female patient that underwent total thyroidectomy in 1985 due to a multinodular goiter and presented postsurgical hypoparathyroidism. The patient missed follow-up apppoointments with Endocrinology and stopped treating her parathyroid condition. Some time later, she presented with change in behavior, drowsiness, paraesthesias, limb spasms and seizures. A CT scan of the brain was performed, showing multiple and extensive calcifications reaching the cerebellar hemispheres, basal ganglia, thalamus and white subcortical substance symmetrically. Laboratory examinations revealed hypocalcemia, hyperphosphatemia, and low parathyroid hormone (PTH) levels. Intravenous calcium gluconate was used to corret the Ca/P dysfunction. Additionally, appropriate antiepileptic drugs for seizures were used. She presented with progressive improvement of symptoms after treatment. Conclusions: This case report demonstrates the importance of post- thyroidectomy follow-up and early recognition of Fahr syndrome’s symptoms, which prevents the progression of neurological conditions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom